Publications by authors named "Scott Schuetze"

80Publications

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

Lancet Oncol 2019 12 6;20(12):1719-1729. Epub 2019 Nov 6.

Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli/Department of Experimental, Diagnostic and Specialty Medicine, Università di Bologna, Bologna, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30663-1DOI Listing
December 2019

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases.

Sarcoma 2019 10;2019:1960593. Epub 2019 Mar 10.

Department of Internal Medicine, University of Michigan, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/1960593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431449PMC
March 2019

PD-1 inhibition in sarcoma still needs investigation - Authors' reply.

Lancet Oncol 2018 01;19(1):e7

Department of Medicine, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30922-1DOI Listing
January 2018

Methotrexate and Vinblastine or Vinorelbine Remain Useful Treatments for Desmoid-Type Fibromatosis 30 Years Later.

Authors:
Scott M Schuetze

Cancer J 2017 Mar/Apr;23(2):92-94

From the Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00130404-201703000-0000
Publisher Site
http://dx.doi.org/10.1097/PPO.0000000000000250DOI Listing
October 2018

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

J Clin Oncol 2016 11 30;34(32):3898-3905. Epub 2016 Sep 30.

Christopher W. Ryan, Oregon Health & Science University, Portland, OR; Ofer Merimsky, Sackler School of Medicine, Tel-Aviv, Israel; Mark Agulnik, Northwestern University, Chicago, IL; Jean-Yves Blay, Centre Léon Bérard, Lyon; Antoine Italiano, Institut Bergonié, Bordeaux, France; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Robin L. Jones and Ian R. Judson, The Royal Marsden Hospital, London, United Kingdom; Anthony D. Elias, University of Colorado-Denver, Aurora, CO; Edwin Choy, Massachusetts General Hospital; Jill Y. Buck and Francois Lebel, ZIOPHARM Oncology, Boston, MA; Thierry Alcindor, McGill University Health Center, Montreal, Quebec, Canada; Vicki L. Keedy, Vanderbilt University Medical Center, Nashville, TN; Damon R. Reed, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Robert N. Taub, Columbia University Medical Center; Jonathan J. Lewis, Samus Therapeutics and Molecular Ninja Group; Robert G. Maki, Mount Sinai School of Medicine, New York, NY; Xavier Garcia del Muro, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain; and Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6684DOI Listing
November 2016

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

J Clin Oncol 2016 Oct;34(30):3680-3685

Vadim S. Koshkin, Cleveland Clinic, Cleveland, OH; Vanessa Bolejack, Cancer Research and Biostatistics, Seattle, WA; Lawrence H. Schwartz, Binsheng Zhao, Columbia University Medical Center, New York, NY; Richard L. Wahl, Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO; Rashmi Chugh, Scott M. Schuetze, Laurence H. Baker, University of Michigan Medical School; Denise K. Reinke, Sarcoma Alliance for Research Through Collaboration, Ann Arbor, MI; Joo H. O, The Catholic University of Korea; Seoul St Mary's Hospital, Seoul, Republic of Korea; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065114PMC
October 2016

Aldoxorubicin in Sarcoma: Teaching an Old Drug New Tricks.

JAMA Oncol 2015 Dec;1(9):1280-1

Division of Hematology/Oncology, Department of Medicine, University of Michigan, Ann Arbor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.3221DOI Listing
December 2015

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy.

Case Rep Oncol Med 2015 22;2015:107479. Epub 2015 Jul 22.

Department of Internal Medicine, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/107479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525456PMC
August 2015

Gastrointestinal stromal tumors, version 2.2014.

J Natl Compr Canc Netw 2014 Jun;12(6):853-62

From Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; The University of Texas MD Anderson Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Roswell Park Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/6/853.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0080DOI Listing
June 2014

Soft tissue sarcoma, version 2.2014.

J Natl Compr Canc Netw 2014 Apr;12(4):473-83

From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/473.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0053DOI Listing
April 2014

Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.

J Bone Joint Surg Am 2014 Jan;96(2):152-8

School of Mathematical Sciences, University College Cork, Western Gateway Building, Western Road, Cork, Ireland. E-mail address for J. O'Sullivan: E-mail address for F. O'Sullivan:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2106/JBJS.M.00062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903137PMC
January 2014

Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors.

Urology 2013 Feb;81(2):347-53

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-5848, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2012.10.016DOI Listing
February 2013

Histology-specific therapy for advanced soft tissue sarcoma and benign connective tissue tumors.

Curr Treat Options Oncol 2012 Sep;13(3):285-98

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-012-0194-4DOI Listing
September 2012

DR6 as a diagnostic and predictive biomarker in adult sarcoma.

PLoS One 2012 2;7(5):e36525. Epub 2012 May 2.

Division of Hematology Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0036525PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342254PMC
September 2012

Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcoma.

Eur J Cancer 2012 Jun 21;48(9):1347-53. Epub 2012 Apr 21.

Division of Hematology/Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI 48109-5848, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.03.022DOI Listing
June 2012

Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial results.

Curr Opin Oncol 2012 Jul;24(4):419-24

Division of Hematology/Oncology, Department of Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-201207000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e328353d78dDOI Listing
July 2012

Bayesian decision theoretic two-stage design in phase II clinical trials with survival endpoint.

Stat Med 2012 Jul 23;31(17):1804-20. Epub 2012 Feb 23.

Biostatistics Unit, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.4511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167619PMC
July 2012

Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.

J Surg Oncol 2011 Dec;104(8):888-95

Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21930DOI Listing
December 2011

Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?

Oncologist 2009 Oct 6;14(10):1003-12. Epub 2009 Oct 6.

University of Michigan, C342 Med Inn, SPC 5848, 1500 E Medical Center Drive, Ann Arbor, Michigan, 48109-5848, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2009-0007DOI Listing
October 2009

[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.

Cancer 2009 Aug;115(15):3519-25

Department of Pediatrics, Seattle Children's Hospital, and Department of Orthopedics, University of Washington, Seattle, Washington 98105-0371, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24421DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716419PMC
August 2009

The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004).

Rare Tumors 2009 Dec 28;1(2):e52. Epub 2009 Dec 28.

Karmanos Cancer Institute and Wayne State University Department of Internal Medicine, Detroit, MI;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/rt.2009.e52DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994468PMC
December 2009

Selection of response criteria for clinical trials of sarcoma treatment.

Oncologist 2008 ;13 Suppl 2:32-40

Department of Internal Medicine, Division of Hematology/Oncology, 1500 E. Medical Center Drive, C409 MIB, Ann Arbor, Michigan 48109-5843, USA. scotschu@umich

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.13-S2-32DOI Listing
July 2008

New targets for therapy of sarcoma.

Curr Opin Oncol 2008 Jul;20(4):400-6

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328303671dDOI Listing
July 2008

Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.

Oncologist 2008 Apr;13(4):459-66

Department of , Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2007-0166DOI Listing
April 2008

Chordoma: the nonsarcoma primary bone tumor.

Oncologist 2007 Nov;12(11):1344-50

Department of Internal Medicine, Division of Hematology/Oncology, 24 Frank Lloyd Wright Drive, A3400, P.O. Box 483, Ann Arbor, Michigan 48106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.12-11-1344DOI Listing
November 2007

Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.

Authors:
Scott M Schuetze

J Natl Compr Canc Netw 2007 Apr;5(4):449-55

Department of Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0848, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2007.0039DOI Listing
April 2007

Targeted therapy for dermatofibrosarcoma protuberans.

Curr Oncol Rep 2006 Jul;8(4):291-6

Division of Hematology/Oncology, Department of Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109-0848, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-006-0035-3DOI Listing
July 2006

Utility of positron emission tomography in sarcomas.

Authors:
Scott M Schuetze

Curr Opin Oncol 2006 Jul;18(4):369-73

Division of Hematology/Oncology, Department of Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0848, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200607000-000
Publisher Site
http://dx.doi.org/10.1097/01.cco.0000228744.49294.12DOI Listing
July 2006

Complications of a temozolomide overdose: a case report.

J Neurooncol 2006 Oct 28;80(1):57-61. Epub 2006 Apr 28.

Department of Neurology, University of Washington School of Medicine, Room RR650, 1959 NE Pacific Street, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-006-9152-yDOI Listing
October 2006

Angiosarcoma metastatic to the orbit.

Ophthalmic Plast Reconstr Surg 2006 Jan-Feb;22(1):62-4

Department of Ophthalmology, University of Washington, Seattle, 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.iop.0000195230.19378.bfDOI Listing
March 2006

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors.

J Clin Oncol 2005 Dec;23(34):8828-34

Children's Hospital and Regional Medical Center, 4800 Sandpoint Way, Mailstop B-6553, Seattle, WA 98105-0371, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.7079DOI Listing
December 2005

Imaging and response in soft tissue sarcomas.

Authors:
Scott M Schuetze

Hematol Oncol Clin North Am 2005 Jun;19(3):471-87, vi

Division of Hematology/Oncology, Box 0848, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0848, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2005.03.001DOI Listing
June 2005

So-called "inflammatory leiomyosarcoma'': a series of 3 cases providing additional insights into a rare entity.

Int J Surg Pathol 2005 Apr;13(2):185-95

Department of Pathology, University of Washington Medical Center, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/106689690501300210DOI Listing
April 2005

Adjuvant therapy for soft tissue sarcoma.

J Natl Compr Canc Netw 2005 Mar;3(2):207-13

Department of Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2005.0013DOI Listing
March 2005

Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.

J Bone Joint Surg Am 2004 ;86-A Suppl 2:98-104

Department of Orthopaedics and Sports Medicine, University of Washington, Seattle 98195-6500, USA.

View Article

Download full-text PDF

Source
March 2005

Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.

Cancer 2005 Jan;103(2):339-48

Department of Medicine, University of Washington Medical Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20769DOI Listing
January 2005

Influence of age upon Ifosfamide-induced nephrotoxicity.

Pediatr Blood Cancer 2004 May;42(5):427-32

University of Washington Medical Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20011DOI Listing
May 2004

FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma.

Skeletal Radiol 2003 Mar 6;32(3):139-42. Epub 2003 Feb 6.

Department of Radiology (Division of Nuclear Medicine), University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-002-0607-8DOI Listing
March 2003

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

J Clin Oncol 2002 Sep;20(17):3586-91

Department of Pathology, University of Washington Medical Center, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.01.027DOI Listing
September 2002